FBRX - Forte Biosciences, Inc.
IEX Last Trade
16
-0.760 -4.750%
Share volume: 72,645
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$16.76
-1.78
-0.10%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-13 | 2024-08-14 | 2024-11-14 | |
| Assets | ||||
| Total Assets | 32.017 M | 26.078 M | 17.946 M | |
| Current Assets | 31.502 M | 25.711 M | 17.668 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 30.444 M | 24.498 M | 16.363 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 106.000 K | 96.000 K | 86.000 K | |
| Other Assets | 409.000 K | 271.000 K | 192.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 32.017 M | 26.078 M | 17.946 M | |
| Total liabilities | 3.332 M | 9.117 M | 8.580 M | |
| Total current liabilities | 3.332 M | 9.117 M | 8.580 M | |
| Accounts Payable | 1.685 M | 5.275 M | 5.159 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 28.685 M | 16.961 M | 9.366 M | |
| Common stock | 154.627 M | 155.419 M | 156.208 M | |
| Retained earnings | -125.940 M | -138.451 M | -146.843 M |